About our Premium Reports
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth is pleased to share with you this report on the Global Digital Health Ecosystem in China. We take a deep look at the macro and microeconomic conditions that make mainland China a hotspot globally for digital health. This is complemented by an analysis on the venture categories, partnerships, key trends, noteworthy deals, exits, and investors.
With unmatched, unparalleled and indispensable coverage of the global digital health ecosystems, this report is powered by HealthTech Alpha, a Galen Growth proprietary solution, and the world’s #1 digital health private market data and analytics platform.
China’s ecosystem is excelling in digital health readiness and implementation, even though the macroeconomic conditions are limiting access to technology in rural parts of the country and slow acceptance due to the low cost of basic care.
The digital health ecosystem feels threatened by governmental probes into data security and new data privacy laws. However, long-term, increased data security regulation could pave the way for Chinese ventures to get a foothold in international ecosystems, such as Europe, and improve overall macroeconomic conditions in China’s Digital Health Readiness Index.
Globally, 11% of venture funding in digital health in H1 2021 was deployed to ventures in China, with cumulative H1 funding of $2.53B, which is a rebound to just above 2019 levels after dropping 72% in H1 2020 amid the uncertainty of the pandemic.
Get the full China Digital Health Ecosystem Analysis and Key Trends Thematic Report to get the complete data and analytics, including:
Digital Health ventures mentioned in the full report includes:
Miaoshou (妙手医生), Yaoshibang (药师帮), Keep (Keep), Supermonkey (超级猩猩), ddky (叮当快药), XtalPi (晶泰科技), MediTrust Health (镁信健康), Yidu Cloud (医渡科技), Basecare Medical (贝康医疗), GeneMind Biosciences (真迈生物), Yitu Medical (依图医疗), More Health (妙健康), AcornMed (金橡医学), Jianke (健客), WeDoctor, Haodf.com, DXY (丁香园), Linkedcare (领健), Chemical.AI (智化科技), Synyi.ai (森亿智能)
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com